**REGISTERED COMPANY NUMBER: 08082786 (England and Wales) REGISTERED CHARITY NUMBER: 1150234**
## **REPORT OF THE TRUSTEES AND**
## **FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **FOR BRITISH NUCLEAR MEDICINE SOCIETY**
E R Grove & Co Limited Grove House Coombs Wood Court Steel Park Road Halesowen West Midlands B62 8BF
**BRITISH NUCLEAR MEDICINE SOCIETY**
## **CONTENTS OF THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
|||**Page**||
|---|---|---|---|
|**Report of the Trustees**|1|to|3|
|**Independent Examiner's Report**||4||
|**Statement of Financial Activities**||5||
|**Balance Sheet**||6||
|**Notes to the Financial Statements**|7|to|12|
**BRITISH NUCLEAR MEDICINE SOCIETY (REGISTERED NUMBER: 08082786)**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2020**
The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 December 2020. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
## **OBJECTIVES AND ACTIVITIES**
## **Objectives and aims**
British Nuclear Medicine Society is dedicated to promoting the multidisciplinary practice of high quality nuclear medicine for the benefit of patients.
The specific objectives of the British Nuclear Medicine Society are to:
1 Raise the profile of nuclear medicine
2 Engage with all health care providers involved in the clinical use of radionuclides
3 Provide a forum for the communication of advances in nuclear medicine
4 Provide resources and encourage the provision of education and training to support continuing professional development.
5 Represent nuclear medicine with official bodies and on advisory committees
6 Develop and promote standards and guidelines for the safe and effective practice of nuclear medicine
7 Promote nuclear medicine research and development
8 Improve the level of support to isolated departments
9 Provide greater information for the benefit of patients
10 Promote and support the recertification/revalidation of practitioners 11 Maintain an appropriate charitable status.
## **Significant activities**
In order for the charity to achieve its aim BNMS engage in the following activities:
- Raising the profile of nuclear medicine through the website, scientific meetings and attendance of careers fairs.
- Engaging with other professional organisations, including British Institute of Radiology, British Cardiology Society, Institute of Physics and Engineering in Medicine, Royal College of Physicians, Royal College of Radiologists, Royal College of Surgeons, Royal College of Nursing, Society and College of Radiographers and Society of Radiological Protection.
- Providing a forum for the communication of advances in nuclear medicine through annual and regional scientific meetings, Nuclear Medicine Communications (the official BNMS journal) and the BNMS website.
- Leading in the provision of education and training to support the development of nuclear medicine
- Representing the specialty on relevant official bodies and advisory committees
- Developing and promoting standards and guidelines for the safe practice of nuclear medicine.
- Promoting nuclear medicine research and development by engaging with academic institutions and industry to promote research leading to new developments and improvements in clinical practice.
## **Public benefit**
The public benefits from the activities of the British Nuclear Medicine Society through the pursuit of its specific objectives including the development and promotion of standards and guidelines for the safe and effective practice of nuclear medicine, the promotion of nuclear medicine research and development and the provision of greater information for the public on the BNMS website.
Page 1
**BRITISH NUCLEAR MEDICINE SOCIETY (REGISTERED NUMBER: 08082786)**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2020**
## **ACHIEVEMENT AND PERFORMANCE**
## **Charitable activities**
The British Nuclear Medicine Society held three scientific and educational meetings this year around the UK, the results of which are as follows:
||**Liverpool**
**(cancelled)**|**Virtual**|**Total**|
|---|---|---|---|
||**£**|**£**|**£**|
|||||
|**Income**||||
|Commercial exhibition income|-|4,500|4,500|
|Annual conference delegate registration fees|-|5,900|5,900|
|||||
||-|10,400|10,400|
|Less: Scientific meeting expenses|489|-7,307|-7,917|
|||||
|Surplus / (deficit)|-489|3,093|2,484|
|||||
## **Fundraising activities**
The British Nuclear Medicine Society generates income from membership fees, from royalties received through "Nuclear Medicine Communications" (the scientific journal of the BNMS) as well registration and exhibitor fees from those attendees at the annual and educational meetings of the Society.
## **Covid-19 Pandemic**
The onset of the Pandemic caused significant disruption to the society's operations and scientific meetings.
The charity has introduced a few changes to our working practices to safeguard our employees and trustees. These include, closing the head office and moving to home working. Reducing the number of staff from three to two.
The charity made the difficult decision to cancel our annual spring meeting in Liverpool and convert our move our autumn meeting in Leeds to an online meeting.
We are pleased that membership numbers have been steady during the year and that most of the costs scientific meeting s that were cancelled, were recovered by the charity for future meetings.
The ongoing pandemic brings continued uncertainty to the wider economy and our own operations. However, the trustees are confident the charity is well placed to deal with these challenges.
## **FUTURE PLANS**
The society will continue to promote the multidisciplinary practice of nuclear medicine for the benefit of patients. It plans to continue holding regular meetings throughout the country and will further encourage regional networks.
## **STRUCTURE, GOVERNANCE AND MANAGEMENT Governing document**
The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006.
## **REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number**
08082786 (England and Wales)
## **Registered Charity number**
1150234
## **Registered office**
Royal College of Physicians 11 St Andrews Place Regents Park London London NW1 4LE
Page 2
## **BRITISH NUCLEAR MEDICINE SOCIETY (REGISTERED NUMBER: 08082786)**
## **REPORT OF THE TRUSTEES FOR THE YEAR ENDED 31 DECEMBER 2020**
## **Trustees**
Mrs J Croasdale Radiopharmacist Dr R Graham Radiologist Dr S Redman Clinical Scientist Mr C S Kalirai Nuclear Medicine Physicist Dr J R Buscombe Nuclear Medicine Physician Mr N Gulliver Nuclear Medicine Technologist (resigned 23.9.20) Dr Y Du Nuclear Medicine Physician (resigned 23.9.20) Dr F X Sundram Physician Dr A G Irwin Clinical Scientist Mr C Mayes Trustee (appointed 23.9.20) Dr A Parthipun Trustee (appointed 23.9.20)
## **Independent Examiner**
E R Grove & Co Limited Grove House Coombs Wood Court Steel Park Road Halesowen West Midlands B62 8BF
Approved by order of the board of trustees on 23 March 2021 and signed on its behalf by:
Dr J R Buscombe - Trustee
Page 3
## **INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF BRITISH NUCLEAR MEDICINE SOCIETY**
## **Independent examiner's report to the trustees of British Nuclear Medicine Society ('the Company')**
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 December 2020.
## **Responsibilities and basis of report**
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').
Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5) (b) of the 2011 Act.
## **Independent examiner's statement**
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:
1. accounting records were not kept in respect of the Company as required by section 386 of the 2006 Act; or 2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).
I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.
Steven Lomas Senior Statutory Auditor E R Grove & Co Limited Grove House Coombs Wood Court Steel Park Road Halesowen West Midlands B62 8BF
23 March 2021
Page 4
## **BRITISH NUCLEAR MEDICINE SOCIETY**
## **STATEMENT OF FINANCIAL ACTIVITIES FOR THE YEAR ENDED 31 DECEMBER 2020**
|Unrestricted
fund
Notes
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
-
Other trading activities
2
82,144
Investment income
3
1,291
Other income
69,981
**Total**
153,416
**EXPENDITURE ON**
Raising funds
4
170,544
**NET INCOME/(EXPENDITURE)**
(17,128)
**RECONCILIATION OF FUNDS**
**Total funds brought forward**
328,375
**TOTAL FUNDS CARRIED FORWARD**
311,247|Restricted
fund
£
-
-
13
-
13
-
13
14,349
14,362|2020
Total
funds
£
-
82,144
1,304
69,981
153,429
170,544
(17,115)
342,724
325,609|2019
Total
funds
£
42
272,789
1,839
51,512|
|---|---|---|---|
||||326,182
297,129|
||||29,053
313,671|
||||342,724|
The notes form part of these financial statements
Page 5
## **BRITISH NUCLEAR MEDICINE SOCIETY (REGISTERED NUMBER: 08082786)**
## **BALANCE SHEET 31 DECEMBER 2020**
|Unrestricted
fund
Notes
£
**FIXED ASSETS**
Tangible assets
9
6,724
**CURRENT ASSETS**
Debtors
10
151,916
Cash at bank
218,350
370,266
**CREDITORS**
Amounts falling due within one year
11
(65,743)
**NET CURRENT ASSETS**
304,523
**TOTAL ASSETS LESS CURRENT LIABILITIES**
311,247
**NET ASSETS**
311,247
**FUNDS**
12
Unrestricted funds
Restricted funds
**TOTAL FUNDS**|Restricted
fund
£
-
-
14,362
14,362
-
14,362
14,362
14,362|2020
Total
funds
£
6,724
151,916
232,712
384,628
(65,743)
318,885
325,609
325,609
311,247
14,362
325,609|2019
Total
funds
£
8,614
156,905
271,401
428,306
(94,196)
334,110
342,724
342,724
328,375
14,349
342,724|
|---|---|---|---|
The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2020.
The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2020 in accordance with Section 476 of the Companies Act 2006.
The trustees acknowledge their responsibilities for
- (a) ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
- (b) preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.
These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.
The financial statements were approved by the Board of Trustees and authorised for issue on 23 March 2021 and were signed on its behalf by:
Dr J R Buscombe - Trustee
The notes form part of these financial statements
Page 6
**BRITISH NUCLEAR MEDICINE SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2020**
## **1. ACCOUNTING POLICIES**
## **Basis of preparing the financial statements**
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.
## **Income**
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.
Exhibition income is recognised in the Statement of Financial Activities in the year that the exhibition is held.
## **Expenditure**
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.
Exhibition expense are recognised in the Statement of Financial Activities in the year that the exhibition is held.
## **Tangible fixed assets**
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 15% on reducing balance Computer equipment - 33% on reducing balance
## **Taxation**
The charity is exempt from corporation tax on its charitable activities.
## **Fund accounting**
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.
Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.
Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.
## **Pension costs and other post-retirement benefits**
The charitable company operates a defined contribution pension scheme. Contributions payable to the charitable company's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.
## **2. OTHER TRADING ACTIVITIES**
|Commercial exhibition income
Annual conference delegate registration fees
Commission received
Royalties received
Other project income|2020
£
4,500
5,900
856
70,617
271
82,144|2019
£
111,313
88,295
870
68,775
3,536|
|---|---|---|
|||272,789|
Page 7
continued...
**BRITISH NUCLEAR MEDICINE SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2020**
## **3. INVESTMENT INCOME**
## **4.**
## **5.**
|Deposit account interest
**RAISING FUNDS**
**Raising donations and legacies**
Support costs
**NET INCOME/(EXPENDITURE)**
Net income/(expenditure) is stated after charging/(crediting):
Other assurance services
Depreciation - owned assets
Deficit on disposal of fixed assets|2020
£
1,304
2020
£
114,832
2020
£
5,000
3,446
248|2019
£
1,839
2019
£
104,235|
|---|---|---|
|||2019
£
3,150
4,238
-|
## **6. TRUSTEES' REMUNERATION AND BENEFITS**
There were no trustees' remuneration or other benefits for the year ended 31 December 2020 nor for the year ended 31 December 2019.
## **Trustees' expenses**
Expenses of £1,355 (2019: £6,135) were paid to the trustees during the year.
## **7. STAFF COSTS**
The average monthly number of employees during the year was as follows:
## **8.**
|Administrative
No employees received emoluments in excess of £60,000.
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES**
Unrestricted
fund
£
**INCOME AND ENDOWMENTS FROM**
Donations and legacies
42
Other trading activities
272,789
Investment income
1,811
Other income
51,512
**Total**
326,154
**EXPENDITURE ON**
Raising funds
297,129
**NET INCOME**
29,025|2020
3
Restricted
fund
£
-
-
28
-
28
-
28|2019
3
Total
funds
£
42
272,789
1,839
51,512|
|---|---|---|
|||326,182
297,129|
|||29,053|
Page 8
continued...
## **BRITISH NUCLEAR MEDICINE SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2020**
|**8.**
**COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued**
Unrestricted
fund
£
**RECONCILIATION OF FUNDS**
**Total funds brought forward**
299,350
**TOTAL FUNDS CARRIED FORWARD**
328,375
**9.**
**TANGIBLE FIXED ASSETS**
Fixtures
and
fittings
£
**COST**
At 1 January 2020
789
Additions
-
Disposals
-
At 31 December 2020
789
**DEPRECIATION**
At 1 January 2020
579
Charge for year
32
Eliminated on disposal
-
At 31 December 2020
611
**NET BOOK VALUE**
At 31 December 2020
178
At 31 December 2019
210
**10.**
**DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
Trade debtors
Other debtors
VAT
Prepayments and accrued income|
Restricted
fund
£
14,321
14,349
Computer
equipment
£
30,944
1,883
(2,725)
30,102
22,540
3,414
(2,398)
23,556
6,546
8,404
2020
£
2,773
60,015
15,067
74,061
151,916||Total
funds
£
313,671|
|---|---|---|---|
||||342,724|
Page 9
continued...
**BRITISH NUCLEAR MEDICINE SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2020**
## **11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR**
|Trade creditors
Social security and other taxes
VAT
Other creditors
Accrued expenses
**MOVEMENT IN FUNDS**
**Unrestricted funds**
General fund
**Restricted funds**
Ross Breen Fund
**TOTAL FUNDS**
Net movement in funds, included in the above are as follows:
**Unrestricted funds**
General fund
**Restricted funds**
Ross Breen Fund
**TOTAL FUNDS**
**Comparatives for movement in funds**
**Unrestricted funds**
General fund
**Restricted funds**
Ross Breen Fund
**TOTAL FUNDS**|At 1.1.20
£
328,375
14,349
342,724
Incoming
resources
£
153,416
13
153,429
At 1.1.19
£
299,350
14,321
313,671|2020
2019
£
£
51,736
19,074
66
-
-
7,119
10,941
65,003
3,000
3,000
65,743
94,196
Net
movement
At
in funds
31.12.20
£
£
(17,128)
311,247
13
14,362
(17,115)
325,609
Resources
Movement
expended
in funds
£
£
(170,544)
(17,128)
-
13
(170,544)
(17,115)
Net
movement
At
in funds
31.12.19
£
£
29,025
328,375
28
14,349
29,053
342,724|
|---|---|---|
## **12. MOVEMENT IN FUNDS**
Page 10
continued...
**BRITISH NUCLEAR MEDICINE SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2020**
## **12. MOVEMENT IN FUNDS - continued**
Comparative net movement in funds, included in the above are as follows:
|**Unrestricted funds**
General fund
**Restricted funds**
Ross Breen Fund
**TOTAL FUNDS**|Incoming
resources
£
326,154
28
326,182|Resources
Movement
expended
in funds
£
£
(297,129)
29,025
-
28
(297,129)
29,053|Resources
Movement
expended
in funds
£
£
(297,129)
29,025
-
28
(297,129)
29,053|
|---|---|---|---|
||||29,053|
A current year 12 months and prior year 12 months combined position is as follows:
|**Unrestricted funds**
General fund
**Restricted funds**
Ross Breen Fund
**TOTAL FUNDS**|At 1.1.19
£
299,350
14,321
313,671|Net
movement
in funds
£
11,897
41
11,938|At
31.12.20
£
311,247
14,362|
|---|---|---|---|
||||325,609|
A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:
|**Unrestricted funds**
General fund
**Restricted funds**
Ross Breen Fund
**TOTAL FUNDS**|Incoming
resources
£
479,570
41
479,611|Resources
Movement
expended
in funds
£
£
(467,673)
11,897
-
41
(467,673)
11,938|Resources
Movement
expended
in funds
£
£
(467,673)
11,897
-
41
(467,673)
11,938|
|---|---|---|---|
||||11,938|
The Ros Breen Fund was established in memory of Ros Breen, who was Superintendent Radiographer in Nuclear Medicine at Southampton General Hospital. The fund is invested in a capital reserve bank account and the interest earned is then used to provide grants to members of the Technology Group.
Page 11
continued...
**BRITISH NUCLEAR MEDICINE SOCIETY**
## **NOTES TO THE FINANCIAL STATEMENTS - continued FOR THE YEAR ENDED 31 DECEMBER 2020**
## **13. RELATED PARTY DISCLOSURES**
There were no related party transactions for the year ended 31 December 2020.
Page 12